Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.
about
Glial cells and chronic painMicroglia in the spinal cord and neuropathic painPeripheral afferent mechanisms underlying acupuncture inhibition of cocaine behavioral effects in ratsToll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia.Pathological pain and the neuroimmune interface.Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic painInvolvement of EphB1 receptors signalling in models of inflammatory and neuropathic pain.The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.Inhibitory effects of intrathecal p38β antisense oligonucleotide on bone cancer pain in ratsPerioperative nerve blockade: clues from the bench.Highly localized interactions between sensory neurons and sprouting sympathetic fibers observed in a transgenic tyrosine hydroxylase reporter mouse.Microglia: a promising target for treating neuropathic and postoperative pain, and morphine toleranceTargeting p38 Mitogen-activated Protein Kinase to Reduce the Impact of Neonatal Microglial Priming on Incision-induced Hyperalgesia in the Adult Rat.GCH1, BH4 and painPriming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity.The preventive effect of resiniferatoxin on the development of cold hypersensitivity induced by spinal nerve ligation: involvement of TRPM8Exogenous nerve growth factor protects the hypoglossal nerve against crush injury.Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerveSuppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.Spinal Cord T-Cell Infiltration in the Rat Spared Nerve Injury Model: A Time Course Study.P2X4R+ microglia drive neuropathic pain.Glial responses after chorda tympani nerve injury.Glia and pain: is chronic pain a gliopathy?Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.Microglia and intractable chronic pain.Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats.Microglia-neuronal signalling in neuropathic pain hypersensitivity 2.0.Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.Bupivacaine effectively relieves inflammation-induced pain by suppressing activation of the NF-κB signalling pathway and inhibiting the activation of spinal microglia and astrocytes.Gene therapy for neuropathic pain induced by spared nerve injury with naked plasmid encoding hepatocyte growth factor.Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.Antihyperalgesic and antidepressive actions of (R)-(+)-limonene, α-phellandrene, and essential oil from Schinus terebinthifolius fruits in a neuropathic pain model.Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats.
P2860
Q24603427-ED78DB55-24A0-4A8B-8BB7-AE5B3D5E2834Q26774353-8CD77C2B-FD35-4729-AE76-A2F889A1D2DEQ28535198-C1CC1A5A-CE7A-48EA-8B2E-55561DA295C0Q33742394-CA9E3BA0-28EB-4709-B65B-38188184B345Q33925677-1FD57F92-B0A2-47F5-BB8D-D62A8D819ED5Q33965479-2718C1A7-13FE-4218-8A5F-AFD08EE065D1Q34558589-511BAF38-D8A5-4334-B232-FDFBC765FD80Q34579481-7A6CA391-8326-4F24-BE00-A8F66A1A576AQ34733108-6ED8204B-6CD1-468F-B2A3-F0D9CA5521F0Q35110316-5B2B630E-F080-491D-A461-0A31BB800230Q35154922-FCBBFB33-DB93-4059-B260-B0B761163682Q35204830-6CFBA61E-4516-4723-BA13-FEAD3F23EADFQ35629354-0E4CF1D4-6B60-4569-B6A3-201C572B6EB4Q35747905-217F0B76-6F65-4428-9A8F-D1C340B50583Q35762455-FC5A1801-0432-4511-875D-97F4CE122B62Q36058246-227349F6-9064-450E-9D5B-96C269C47413Q36514036-0BF952B9-0F1D-41DC-B87C-D3046E035FF5Q36585428-C6354982-7E0D-4311-AD19-8505FE7B3A5DQ36644488-BC98211B-0E69-4FFA-B7D2-0AB1FD0D8428Q36743645-AB6629EB-A969-4CE4-910F-2440D415984CQ37256253-20A822B7-0F31-451A-8613-20C8DABB93F4Q37276340-745D997B-CB45-4460-9B19-A4064E7C7D1FQ37381399-BE75EDF1-385E-45DA-A1D0-4367111770D3Q37988158-5B4F6D36-2BDA-40B7-8D46-A6CD2A38E3BCQ38022210-B5A2C3C7-540D-409F-B065-C0611B620371Q38206127-25C00A52-42F6-46D6-99E4-B9BC3A64046BQ39248070-B78CB6D8-EFED-467A-B552-A0342CDCCA87Q40277139-F8FD0BAD-1EAA-4990-98AE-92D606661496Q41553356-42AE7B0A-1B61-4984-810B-63698CAAB391Q41785702-CFFF8F26-E1BB-4765-9976-65581746B899Q42290631-3192BF45-3CC2-49CD-81C0-FB4FA5ABE942Q45873482-882F7EED-8D89-4B8B-9FD8-183D681D5C4FQ47732599-F8B520C7-1C56-475D-90FE-DE0F64366ECEQ48328170-8979C44C-E710-4F36-9796-75ABEF5E089AQ50903814-177930B4-FE92-407A-B092-2888994D9C39
P2860
Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Large A-fiber activity is requ ...... ges after spared nerve injury.
@en
Large A-fiber activity is requ ...... ges after spared nerve injury.
@nl
type
label
Large A-fiber activity is requ ...... ges after spared nerve injury.
@en
Large A-fiber activity is requ ...... ges after spared nerve injury.
@nl
prefLabel
Large A-fiber activity is requ ...... ges after spared nerve injury.
@en
Large A-fiber activity is requ ...... ges after spared nerve injury.
@nl
P2860
P50
P356
P1433
P1476
Large A-fiber activity is requ ...... ges after spared nerve injury.
@en
P2093
Isabelle Decosterd
Marc R Suter
P2860
P2888
P356
10.1186/1744-8069-5-53
P577
2009-09-22T00:00:00Z
P5875
P6179
1050369863